Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218036 · ClinicalTrials.gov registry record · Phase 2
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00218036: Clinical Trial Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
NCT00218036 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 54 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218036, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.
Interventions
- DRUG Placebo
- DRUG Citalopram 20mg
- DRUG Modafinil 200mg
- DRUG Modafinil 400mg
- DRUG Citalopram 40mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-07 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Why NCT00218036 stopped before completion
NCT00218036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00218036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218036 about?
NCT00218036 is a clinical study titled "Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8". The purpose of this study is to examine two medications, modafinil and citalopram, in the treatment of cocaine dependent individuals who are maintained on methadone.
What is the current status of trial NCT00218036?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2006-07. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00218036?
The interventions under investigation include: Placebo (DRUG), Citalopram 20mg (DRUG), Modafinil 200mg (DRUG), Modafinil 400mg (DRUG), Citalopram 40mg (DRUG).
Who is sponsoring clinical trial NCT00218036?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218036's enrollment target sits among peer trials
54 1160th of 2000 higher than 830 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia